RAYMOND JAMES & ASSOCIATES

Holdings History for BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0

Investment type: Debt / NOTE 0.599% 8/0

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Principal	Change	Activity %	Price	All Holders
30 Sep 2024		-0%	$0	0	-72,000	-100%		Q3 2024
30 Jun 2024	0%	+0%	$71,410	72,000	+57,000	+380%	99.18%	Q2 2024
31 Mar 2024	0%	0%	$14,729	15,000	0		98.19%	Q1 2024
31 Dec 2023	0%	0%	$14,784	15,000	0		98.56%	Q4 2023
30 Sep 2023	0%	0%	$14,550	15,000	0		97.0%	Q3 2023
30 Jun 2023	0%	0%	$14,734	15,000	0		98.23%	Q2 2023
31 Mar 2023	0%	0%	$15,390	15,000	0		102.6%	Q1 2023
31 Dec 2022	0%	0%	$15,920	15,000	0		106.13%	Q4 2022
30 Sep 2022	0%	0%	$15,000	15,000	0		100.0%	Q3 2022
30 Jun 2022	0%	0%	$15,000	15,000	0		100.0%	Q2 2022
31 Mar 2022	0%	0%	$15,000	15,000	0		100.0%	Q1 2022
31 Dec 2021	0%	0%	$16,000	15,000	0		106.67%	Q4 2021
30 Sep 2021	0%	0%	$15,000	15,000	0		100.0%	Q3 2021
30 Jun 2021	0%	0%	$16,000	15,000	0		106.67%	Q2 2021
31 Mar 2021	0%	0%	$15,000	15,000	0		100.0%	Q1 2021
31 Dec 2020	0%	+0%	$16,000	15,000	+15,000	NEW	106.67%	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.